- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondria as Therapeutic Targets in Heart Failure
Authors
Keywords
-
Journal
Current Heart Failure Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-12
DOI
10.1007/s11897-022-00539-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Cardiac Late Sodium Channel Current is a Molecular Target for the Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin
- (2021) Koenraad Philippaert et al. CIRCULATION
- Effects of Elamipretide on Left Ventricular Function in Patients with Heart Failure with Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial
- (2020) Javed Butler et al. JOURNAL OF CARDIAC FAILURE
- A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
- (2020) Amel Karaa et al. Journal of Cachexia Sarcopenia and Muscle
- Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events
- (2020) Valentina Spigoni et al. Cardiovascular Diabetology
- Role of Deranged Energy Deprivation Signaling in the Pathogenesis of Cardiac and Renal Disease in States of Perceived Nutrient Overabundance
- (2020) Milton Packer CIRCULATION
- Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
- (2020) Mark C. Petrie et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in patients with peripheral artery disease
- (2020) Song-Young Park et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats
- (2020) Mitchell E. Allen et al. Communications Biology
- A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism
- (2020) W. Reid Thompson et al. GENETICS IN MEDICINE
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
- (2020) Faiez Zannad et al. LANCET
- Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial
- (2020) Roberto Ferrari et al. LANCET
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status
- (2020) Stefan D. Anker et al. CIRCULATION
- Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF
- (2020) Yan Deng et al. CIRCULATION RESEARCH
- Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial
- (2019) David Fitchett et al. CIRCULATION
- Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice
- (2019) Kah Yong Goh et al. Redox Biology
- Trimetazidine in cardiovascular medicine
- (2019) Mario Marzilli et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
- (2019) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- (2019) Juhani Knuuti et al. EUROPEAN HEART JOURNAL
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Calcium Signaling and Reactive Oxygen Species in Mitochondria
- (2018) Edoardo Bertero et al. CIRCULATION RESEARCH
- MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload
- (2018) Rogério Faustino Ribeiro Junior et al. FREE RADICAL BIOLOGY AND MEDICINE
- Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older AdultsNovelty and Significance
- (2018) Matthew J. Rossman et al. HYPERTENSION
- Metabolic remodelling in heart failure
- (2018) Edoardo Bertero et al. Nature Reviews Cardiology
- Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy
- (2018) Amel Karaa et al. NEUROLOGY
- Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation
- (2018) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- AMPKα2 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation
- (2017) Bei Wang et al. CIRCULATION RESEARCH
- Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload–Induced Mitochondrial Dysfunction and Heart FailureCLINICAL PERSPECTIVE
- (2016) Akihiro Shirakabe et al. CIRCULATION
- Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure
- (2016) Kenneth C. Bedi et al. CIRCULATION
- The Failing Heart Relies on Ketone Bodies as a Fuel
- (2016) Gregory Aubert et al. CIRCULATION
- Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
- (2016) Ele Ferrannini et al. DIABETES
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
- (2016) Volker Vallon et al. DIABETOLOGIA
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure
- (2016) Yuri M. Lopatin et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology
- (2016) Nico Hartmann et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardioprotection and lifespan extension by the natural polyamine spermidine
- (2016) Tobias Eisenberg et al. NATURE MEDICINE
- Cardiomyocyte mitochondrial oxidative stress and cytoskeletal breakdown in the heart with a primary volume overload
- (2015) Danielle M. Yancey et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure
- (2015) Alexander G. Nickel et al. Cell Metabolism
- The HARMONY Trial
- (2015) James A. Reiffel et al. Circulation-Arrhythmia and Electrophysiology
- EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention
- (2015) C. Michael Gibson et al. EUROPEAN HEART JOURNAL
- Deranged sodium to sudden death
- (2015) Colleen E. Clancy et al. JOURNAL OF PHYSIOLOGY-LONDON
- Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart
- (2015) Jianru Shi et al. LIFE SCIENCES
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibiting Mitochondrial Na + /Ca 2+ Exchange Prevents Sudden Death in a Guinea Pig Model of Heart Failure
- (2014) Ting Liu et al. CIRCULATION RESEARCH
- Bendavia, a Mitochondria-targeting Peptide, Improves Postinfarction Cardiac Function, Prevents Adverse Left Ventricular Remodeling, and Restores Mitochondria-related Gene Expression in Rats
- (2014) Wangde Dai et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics
- (2013) Hazel H Szeto BRITISH JOURNAL OF PHARMACOLOGY
- Targeting mitochondrial cardiolipin and the cytochromec/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis
- (2013) A V Birk et al. BRITISH JOURNAL OF PHARMACOLOGY
- Global Proteomics and Pathway Analysis of Pressure-Overload–Induced Heart Failure and Its Attenuation by Mitochondrial-Targeted Peptides
- (2013) Dao-Fu Dai et al. Circulation-Heart Failure
- Reduction of Early Reperfusion Injury With the Mitochondria-Targeting Peptide Bendavia
- (2013) David A. Brown et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Intracellular Na+ and cardiac metabolism
- (2013) Johannes Bay et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy
- (2012) Peng Zhao et al. LIFE SCIENCES
- Reduction of Ischemia/Reperfusion Injury With Bendavia, a Mitochondria‐Targeting Cytoprotective Peptide
- (2012) Robert A. Kloner et al. Journal of the American Heart Association
- Mitochondrial Targeted Antioxidant Peptide Ameliorates Hypertensive Cardiomyopathy
- (2011) Dao-Fu Dai et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated Cytosolic Na + Increases Mitochondrial Formation of Reactive Oxygen Species in Failing Cardiac Myocytes
- (2010) Michael Kohlhaas et al. CIRCULATION
- Adverse Bioenergetic Consequences of Na + -Ca 2+ Exchanger–Mediated Ca 2+ Influx in Cardiac Myocytes
- (2010) Michael Kohlhaas et al. CIRCULATION
- Role of mitochondrial dysfunction in cardiac glycoside toxicity
- (2010) Ting Liu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Altered Na+Currents in Atrial Fibrillation
- (2010) Samuel Sossalla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients
- (2010) Edward J. Gane et al. LIVER INTERNATIONAL
- A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
- (2010) Barry J. Snow et al. MOVEMENT DISORDERS
- Sodium-Hydrogen Exchange Inhibition by Cariporide to Reduce the Risk of Ischemic Cardiac Events in Patients Undergoing Coronary Artery Bypass Grafting: Results of the EXPEDITION Study
- (2008) Robert M. Mentzer et al. ANNALS OF THORACIC SURGERY
- Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy
- (2008) Helena Tuunanen et al. CIRCULATION
- Enhancing Mitochondrial Ca 2+ Uptake in Myocytes From Failing Hearts Restores Energy Supply and Demand Matching
- (2008) Ting Liu et al. CIRCULATION RESEARCH
- Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury
- (2007) Hazel H. Szeto ANTIOXIDANTS & REDOX SIGNALING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search